Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Oct;151(4):975–983.

Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras.

M Christofidou-Solomidou 1, M Bridges 1, G F Murphy 1, S M Albelda 1, H M DeLisser 1
PMCID: PMC1858044  PMID: 9327731

Abstract

Accumulating evidence indicates that endothelial cell integrins that bind to the matrix proteins associated with inflammation and wound healing are involved in the process of angiogenesis. The integrins containing the alpha v subunit appear to be particularly important. To study the involvement of these receptors in human angiogenesis, a model of wound-associated human angiogenesis was established in human skin transplanted onto severe combined immunodeficient (SCID) mice. Using this model, we studied the expression of several alpha v integrins and tested the hypothesis that blockage of the alpha v beta 3 integrin would inhibit human angiogenesis during human wound healing. These studies revealed that the alpha v beta 3, alpha v beta 5, and alpha v beta 6 integrins are up-regulated briefly during wound angiogenesis with different patterns of expression and that inhibition of the alpha v beta 3 integrin blocked new vessel formation during human wound healing.

Full text

PDF
975

Images in this article

978Figure 1
on p.978
979Figure 2
on p.979
980Figure 4
on p.980
981Figure 5
on p.981

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M., Daise M., Levine E. M., Buck C. A. Identification and characterization of cell-substratum adhesion receptors on cultured human endothelial cells. J Clin Invest. 1989 Jun;83(6):1992–2002. doi: 10.1172/JCI114109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albelda S. M. Differential expression of integrin cell-substratum adhesion receptors on endothelium. EXS. 1992;61:188–192. doi: 10.1007/978-3-0348-7001-6_28. [DOI] [PubMed] [Google Scholar]
  3. Albelda S. M., Mette S. A., Elder D. E., Stewart R., Damjanovich L., Herlyn M., Buck C. A. Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression. Cancer Res. 1990 Oct 15;50(20):6757–6764. [PubMed] [Google Scholar]
  4. Arnold F., West D. C. Angiogenesis in wound healing. Pharmacol Ther. 1991 Dec;52(3):407–422. doi: 10.1016/0163-7258(91)90034-j. [DOI] [PubMed] [Google Scholar]
  5. Barnhill R. L., Wolf J. E., Jr Angiogenesis and the skin. J Am Acad Dermatol. 1987 Jun;16(6):1226–1242. doi: 10.1016/s0190-9622(87)70161-3. [DOI] [PubMed] [Google Scholar]
  6. Breuss J. M., Gallo J., DeLisser H. M., Klimanskaya I. V., Folkesson H. G., Pittet J. F., Nishimura S. L., Aldape K., Landers D. V., Carpenter W. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 1995 Jun;108(Pt 6):2241–2251. doi: 10.1242/jcs.108.6.2241. [DOI] [PubMed] [Google Scholar]
  7. Brooks P. C., Clark R. A., Cheresh D. A. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994 Apr 22;264(5158):569–571. doi: 10.1126/science.7512751. [DOI] [PubMed] [Google Scholar]
  8. Brooks P. C., Montgomery A. M., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., Cheresh D. A. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 1994 Dec 30;79(7):1157–1164. doi: 10.1016/0092-8674(94)90007-8. [DOI] [PubMed] [Google Scholar]
  9. Brooks P. C., Strömblad S., Klemke R., Visscher D., Sarkar F. H., Cheresh D. A. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest. 1995 Oct;96(4):1815–1822. doi: 10.1172/JCI118227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brooks P. C., Strömblad S., Sanders L. C., von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., Quigley J. P., Cheresh D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996 May 31;85(5):683–693. doi: 10.1016/s0092-8674(00)81235-0. [DOI] [PubMed] [Google Scholar]
  11. Cheresh D. A., Spiro R. C. Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987 Dec 25;262(36):17703–17711. [PubMed] [Google Scholar]
  12. Christofidou-Solomidou M., Murphy G. F., Albelda S. M. Induction of E-selectin-dependent leukocyte recruitment by mast cell degranulation in human skin grafts transplanted on SCID mice. Am J Pathol. 1996 Jan;148(1):177–188. [PMC free article] [PubMed] [Google Scholar]
  13. Christofidou-Solomidou M., Nakada M. T., Williams J., Muller W. A., DeLisser H. M. Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J Immunol. 1997 May 15;158(10):4872–4878. [PubMed] [Google Scholar]
  14. Clark R. A., Tonnesen M. G., Gailit J., Cheresh D. A. Transient functional expression of alphaVbeta 3 on vascular cells during wound repair. Am J Pathol. 1996 May;148(5):1407–1421. [PMC free article] [PubMed] [Google Scholar]
  15. Davis C. M., Danehower S. C., Laurenza A., Molony J. L. Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J Cell Biochem. 1993 Feb;51(2):206–218. doi: 10.1002/jcb.240510213. [DOI] [PubMed] [Google Scholar]
  16. Dejana E., Raiteri M., Resnati M., Lampugnani M. G. Endothelial integrins and their role in maintaining the integrity of the vessel wall. Kidney Int. 1993 Jan;43(1):61–65. doi: 10.1038/ki.1993.11. [DOI] [PubMed] [Google Scholar]
  17. Drake C. J., Cheresh D. A., Little C. D. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J Cell Sci. 1995 Jul;108(Pt 7):2655–2661. doi: 10.1242/jcs.108.7.2655. [DOI] [PubMed] [Google Scholar]
  18. Enenstein J., Kramer R. H. Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin. J Invest Dermatol. 1994 Sep;103(3):381–386. doi: 10.1111/1523-1747.ep12395390. [DOI] [PubMed] [Google Scholar]
  19. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995 Dec 28;333(26):1757–1763. doi: 10.1056/NEJM199512283332608. [DOI] [PubMed] [Google Scholar]
  20. Folkman J., Shing Y. Angiogenesis. J Biol Chem. 1992 Jun 5;267(16):10931–10934. [PubMed] [Google Scholar]
  21. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990 Jan 3;82(1):4–6. doi: 10.1093/jnci/82.1.4. [DOI] [PubMed] [Google Scholar]
  22. Friedlander M., Brooks P. C., Shaffer R. W., Kincaid C. M., Varner J. A., Cheresh D. A. Definition of two angiogenic pathways by distinct alpha v integrins. Science. 1995 Dec 1;270(5241):1500–1502. doi: 10.1126/science.270.5241.1500. [DOI] [PubMed] [Google Scholar]
  23. Friedlander M., Theesfeld C. L., Sugita M., Fruttiger M., Thomas M. A., Chang S., Cheresh D. A. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9764–9769. doi: 10.1073/pnas.93.18.9764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Furcht L. T. Critical factors controlling angiogenesis: cell products, cell matrix, and growth factors. Lab Invest. 1986 Nov;55(5):505–509. [PubMed] [Google Scholar]
  25. Hammes H. P., Brownlee M., Jonczyk A., Sutter A., Preissner K. T. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med. 1996 May;2(5):529–533. doi: 10.1038/nm0596-529. [DOI] [PubMed] [Google Scholar]
  26. Herlyn M., Graeven U., Speicher D., Sela B. A., Bennicelli J. L., Kath R., Guerry D., 4th Characterization of tenascin secreted by human melanoma cells. Cancer Res. 1991 Sep 15;51(18):4853–4858. [PubMed] [Google Scholar]
  27. Juhasz I., Albelda S. M., Elder D. E., Murphy G. F., Adachi K., Herlyn D., Valyi-Nagy I. T., Herlyn M. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol. 1993 Aug;143(2):528–537. [PMC free article] [PubMed] [Google Scholar]
  28. Juhasz I., Albelda S. M., Elder D. E., Murphy G. F., Adachi K., Herlyn D., Valyi-Nagy I. T., Herlyn M. Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol. 1993 Aug;143(2):528–537. [PMC free article] [PubMed] [Google Scholar]
  29. Klein S., Giancotti F. G., Presta M., Albelda S. M., Buck C. A., Rifkin D. B. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell. 1993 Oct;4(10):973–982. doi: 10.1091/mbc.4.10.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Luna J., Tobe T., Mousa S. A., Reilly T. M., Campochiaro P. A. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model. Lab Invest. 1996 Oct;75(4):563–573. [PubMed] [Google Scholar]
  31. McCormick B. A., Zetter B. R. Adhesive interactions in angiogenesis and metastasis. Pharmacol Ther. 1992;53(2):239–260. doi: 10.1016/0163-7258(92)90011-n. [DOI] [PubMed] [Google Scholar]
  32. Nicosia R. F., Bonanno E. Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am J Pathol. 1991 Apr;138(4):829–833. [PMC free article] [PubMed] [Google Scholar]
  33. Pasqualini R., Bodorova J., Ye S., Hemler M. E. A study of the structure, function and distribution of beta 5 integrins using novel anti-beta 5 monoclonal antibodies. J Cell Sci. 1993 May;105(Pt 1):101–111. doi: 10.1242/jcs.105.1.101. [DOI] [PubMed] [Google Scholar]
  34. Peltonen J., Larjava H., Jaakkola S., Gralnick H., Akiyama S. K., Yamada S. S., Yamada K. M., Uitto J. Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas. J Clin Invest. 1989 Dec;84(6):1916–1923. doi: 10.1172/JCI114379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Polverini P. J. Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am J Pathol. 1996 Apr;148(4):1023–1029. [PMC free article] [PubMed] [Google Scholar]
  36. Soballe P. W., Montone K. T., Satyamoorthy K., Nesbit M., Herlyn M. Carcinogenesis in human skin grafted to SCID mice. Cancer Res. 1996 Feb 15;56(4):757–764. [PubMed] [Google Scholar]
  37. Vaporciyan A. A., DeLisser H. M., Yan H. C., Mendiguren I. I., Thom S. R., Jones M. L., Ward P. A., Albelda S. M. Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science. 1993 Dec 3;262(5139):1580–1582. doi: 10.1126/science.8248808. [DOI] [PubMed] [Google Scholar]
  38. Varner J. A., Brooks P. C., Cheresh D. A. REVIEW: the integrin alpha V beta 3: angiogenesis and apoptosis. Cell Adhes Commun. 1995 Nov;3(4):367–374. doi: 10.3109/15419069509081020. [DOI] [PubMed] [Google Scholar]
  39. Wayner E. A., Orlando R. A., Cheresh D. A. Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface. J Cell Biol. 1991 May;113(4):919–929. doi: 10.1083/jcb.113.4.919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Weinacker A., Chen A., Agrez M., Cone R. I., Nishimura S., Wayner E., Pytela R., Sheppard D. Role of the integrin alpha v beta 6 in cell attachment to fibronectin. Heterologous expression of intact and secreted forms of the receptor. J Biol Chem. 1994 Mar 4;269(9):6940–6948. [PubMed] [Google Scholar]
  41. Weinstat-Saslow D., Steeg P. S. Angiogenesis and colonization in the tumor metastatic process: basic and applied advances. FASEB J. 1994 Apr 1;8(6):401–407. doi: 10.1096/fasebj.8.6.7513289. [DOI] [PubMed] [Google Scholar]
  42. Yan H. C., Baldwin H. S., Sun J., Buck C. A., Albelda S. M., DeLisser H. M. Alternative splicing of a specific cytoplasmic exon alters the binding characteristics of murine platelet/endothelial cell adhesion molecule-1 (PECAM-1). J Biol Chem. 1995 Oct 6;270(40):23672–23680. doi: 10.1074/jbc.270.40.23672. [DOI] [PubMed] [Google Scholar]
  43. Yan H. C., Delisser H. M., Pilewski J. M., Barone K. M., Szklut P. J., Chang X. J., Ahern T. J., Langer-Safer P., Albelda S. M. Leukocyte recruitment into human skin transplanted onto severe combined immunodeficient mice induced by TNF-alpha is dependent on E-selectin. J Immunol. 1994 Mar 15;152(6):3053–3063. [PubMed] [Google Scholar]
  44. Yan H. C., Juhasz I., Pilewski J., Murphy G. F., Herlyn M., Albelda S. M. Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest. 1993 Mar;91(3):986–996. doi: 10.1172/JCI116320. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES